Evaluation of Heavy Menstrual Bleeding in Transfusion-Dependent Thalassemia Females
In transfusion-dependent thalassemia females with heavy menstrual bleeding, you must evaluate for underlying bleeding disorders (von Willebrand disease, platelet dysfunction), assess iron status despite transfusion dependence, and rule out structural gynecologic pathology.
Essential Laboratory Testing
Hemostasis Evaluation
The evaluation must include comprehensive bleeding disorder screening, as 11-16% of women with heavy menstrual bleeding and normal gynecologic evaluation will have von Willebrand disease, with additional patients showing platelet dysfunction 1. Testing should include:
- Von Willebrand factor panel (VWF:Ag, VWF:RCo, Factor VIII activity) 2
- Complete blood count with platelet count 3
- Prothrombin time (PT/INR) and activated partial thromboplastin time (aPTT) 3
- Platelet function testing if initial VWF testing is normal 1
- Thrombin generation assays may identify coagulation defects, as studies show over 40% of women with unexplained heavy menstrual bleeding have impaired platelet function or coagulation 4
Iron Status Assessment
Despite regular transfusions, iron parameters require evaluation:
- Serum ferritin - though this will be elevated in transfusion-dependent patients, trending values remain important 5
- Transferrin saturation - more reliable than ferritin in assessing functional iron availability 5
- Hemoglobin levels - to assess adequacy of transfusion regimen 6
- MRI liver iron concentration (R2, T2, or R2)** - essential for quantifying iron overload in chronically transfused patients 7
The ferritin level in transfusion-dependent patients is typically elevated and serves as an acute-phase reactant, making transferrin saturation a more reliable marker 5.
Gynecologic Evaluation
Structural causes must be excluded:
- Pelvic examination and imaging (ultrasound or MRI) to rule out endometrial hyperplasia, malignancy, fibroids, or polyps 8, 9
- Endometrial assessment particularly important given that heavy menstrual bleeding can mask more serious pathology 8
Clinical History Components
Document specific bleeding characteristics that predict underlying disorders:
- Menstrual duration >7 days
- Soaking >5 sanitary products per day or requiring nighttime changes
- Passage of blood clots ≥1 inch diameter 9, 10
- "Flooding" requiring pad/tampon change more frequently than hourly 9
- Personal and family history of other bleeding symptoms 2, 10
Additional Considerations
Thalassemia-Specific Factors
- Mean corpuscular volume (MCV) of parents - if <80 fL, consider DNA testing for alpha-thalassemia variants 11
- Cardiac T2 MRI* - if evidence of significant iron overload (liver iron >15 mg/g for >2 years) or cardiac dysfunction 7
- Endocrine screening - as iron overload can cause hypothyroidism, diabetes, and hypogonadism affecting menstrual patterns 7
Pitfalls to Avoid
Do not assume heavy menstrual bleeding is simply due to the underlying thalassemia diagnosis. The coexistence of a bleeding disorder is common and treatable. Similarly, do not rely solely on ferritin levels in transfusion-dependent patients, as inflammation and iron overload make interpretation difficult 5.
Do not delay hematology consultation when flooding, prolonged menses, or failure to respond to conventional hormonal therapy occurs, as this strongly suggests an underlying bleeding disorder requiring specialized hemostatic management 9, 10.
Multidisciplinary Approach
Management requires coordination between:
- Hematologist - for bleeding disorder diagnosis, iron chelation optimization, and transfusion management 8
- Gynecologist - for structural evaluation and hormonal management 8
- Interventional radiology - if procedural intervention needed for acute hemorrhage 8
Ideally, evaluation occurs in a multidisciplinary clinic where both hematology and gynecology expertise are available simultaneously to facilitate shared decision-making 8.